$6.25
-0.47 (-6.99%)
Open$6.48
Previous Close$6.72
Day High$6.70
Day Low$6.19
52W High$80.10
52W Low$2.98
Volume—
Avg Volume68.6K
Market Cap3.85M
P/E Ratio—
EPS$-1.51
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 26.12M | 1.37M | 1.35M |
| Net Income | -125,669,999 | 393.8K | 424.2K |
| Profit Margin | -481.2% | 28.8% | 31.3% |
| EBITDA | -136,669,089 | 809.4K | 830.6K |
| Free Cash Flow | — | 304.8K | 355.4K |
| Rev Growth | — | -0.9% | -3.8% |
| Debt/Equity | 0.01 | 0.83 | 1.09 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $948.45 | -2.72% | 36.1 | 913.24B |
| JNJ | Johnson & Johnson | $221.32 | -0.53% | 26.1 | 548.94B |
| MRK | Merck & Co. Inc. | $111.38 | -0.82% | 31.3 | 279.42B |
| PFE | Pfizer Inc. | $25.68 | -3.02% | 19.3 | 150.09B |
| BMY | Bristol-Myers Squibb Co | $56.16 | -0.16% | 17.0 | 120.08B |
| ZTS | Zoetis Inc | $82.83 | -5.13% | 21.5 | 57.37B |